| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/15/2004 | US20040071662 Dendritic cells; methods |
| 04/15/2004 | US20040071658 Vaccine immunotherapy for immune suppressed patients |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | US20040071637 Method for repairing a damaged portion of a human organ |
| 04/15/2004 | DE10245927A1 Expanding post-embryonal stem cells, useful for therapeutic transplantation, by growing in presence of modified glycan to inhibit differentiation |
| 04/15/2004 | CA2501280A1 Cell culture |
| 04/15/2004 | CA2501218A1 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 04/15/2004 | CA2501001A1 Human foreskin cells suitable for culturing stem cells |
| 04/15/2004 | CA2500962A1 Uses of human zven proteins and polynucleotides |
| 04/15/2004 | CA2500673A1 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | CA2500421A1 Cell adhesion resisting surfaces |
| 04/15/2004 | CA2500410A1 Programmable scaffold and methods for making and using the same |
| 04/15/2004 | CA2500408A1 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
| 04/14/2004 | EP1408112A1 MONOCLONAL ANTIBODY BINDING TO MT4−MMP CATALYTIC DOMAIN |
| 04/14/2004 | EP1408109A1 Novel transformed cells, method of screening antiaging agent and antiaging agents |
| 04/14/2004 | EP1408106A1 Cancer immuno-therapy |
| 04/14/2004 | EP1408105A1 Device and method for cultivation |
| 04/14/2004 | EP1408049A2 A novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 04/14/2004 | EP1407788A2 Myoblast therapy for mammalian diseases |
| 04/14/2004 | EP1407781A1 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 04/14/2004 | EP1407661A1 Transgenic animal transformed using green fluorescent protein gene |
| 04/14/2004 | EP1407261A1 In vivo bioreactors |
| 04/14/2004 | EP1407202A1 Cryopreservation system with controlled dendritic freezing front velocity |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407034A2 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407023A2 Group b streptococcus antigens and corresponding dna fragments |
| 04/14/2004 | EP1407019A2 Intestinal proteins |
| 04/14/2004 | EP1407017A2 Human tumor necrosis factor receptor |
| 04/14/2004 | EP1407015A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407010A1 Regulation of human aminopeptidase n |
| 04/14/2004 | EP1407005A2 Integrative assays for monitoring molecular assembly events |
| 04/14/2004 | EP1407004A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 04/14/2004 | EP1407003A1 Liver cell progenitor and use for treatment of liver diseases |
| 04/14/2004 | EP1407002A2 A bioprocess for the generation of cells derived from spheroid-forming cells |
| 04/14/2004 | EP1407001A1 Disposable vessel |
| 04/14/2004 | EP1406998A2 Liver engrafting cells, assays, and uses thereof |
| 04/14/2004 | EP1406931A2 Modification of human variable domains |
| 04/14/2004 | EP1406929A2 Glycoprotein vi fusion proteins |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406925A2 Survivin interacting protein tpr1 |
| 04/14/2004 | EP1406923A2 Histidine phosphatase interacting protein with 180kd |
| 04/14/2004 | EP1406915A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406680A1 Biofunctional fibers |
| 04/14/2004 | EP1406666A2 Adenoviral vectors with cell type specificity for mesenchymal cells |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406645A2 Novel human transporter proteins and polynucleotides encoding the same |
| 04/14/2004 | EP1406573A2 Conditioned cell culture media and uses thereof |
| 04/14/2004 | EP1406561A2 Tissue engineered heart valve |
| 04/14/2004 | EP1351696A4 Composition for delivery of hematopoietic growth factor |
| 04/14/2004 | EP1242578B1 Cell culture medim containing growth factors and l-glutamine |
| 04/14/2004 | EP1238278A4 Sperm quality assay |
| 04/14/2004 | EP1036185B1 Proteinase inhibitor fusion proteins |
| 04/14/2004 | EP0870044B1 Regulated protein expression in stably transfected mammalian cells |
| 04/14/2004 | EP0800574B1 Biomaterial and method for obtaining it |
| 04/14/2004 | EP0765392B1 Interleukin-5 specific recombinant antibodies |
| 04/14/2004 | CN1489692A HCV antigen/antibody combination assay |
| 04/14/2004 | CN1489630A HIV-like particles and use thereof |
| 04/14/2004 | CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 04/14/2004 | CN1489627A Method and compositions for synthesis of nuclear acid molecules using multiple recognition sites |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/14/2004 | CN1489471A Educated NKT cells and their uses in the treatment of immune-related disorder |
| 04/14/2004 | CN1488642A Paddy rice ethylene receptor protein, coded gene and use thereof |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145698C Synthetic insecticide crystalline protein gene |
| 04/14/2004 | CN1145694C Novel human thrombopoietin mutein |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
| 04/13/2004 | US6720488 Transgenic maize seed and method for controlling insect pests |
| 04/13/2004 | US6720485 In tomatoes; selecting individuals of of plants derived from interspecific crosses of lycopersicon spp. with lycopersicon esculentum genotypes, and selecting those that contain an allele of a gene that increases starch synthesis |
| 04/13/2004 | US6720484 Potato cultivar FL1879 |
| 04/13/2004 | US6720408 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal |
| 04/13/2004 | US6720310 Transfer method for specific cellular localization of nucleic acids |
| 04/13/2004 | US6720191 Direct extraction of cellular material from a tissue sample occurs to a transfer surface. |
| 04/13/2004 | US6720183 Cytoplasmic inhibition of gene expression |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720167 Nucleic acid sequence comprising in order a b. thuringiensis cry promoter; a bacteria stab-si sequence, a ribosome binding site, and a sequence encoding one or both proteins of a b. sphaericus binary toxin. |
| 04/13/2004 | US6720156 Monoclonal antibody; for use in the treatment, diagnosis, screening, and imaging of joint defects |
| 04/13/2004 | US6720153 Luciferase reporter bioassay of parathyroid hormone compounds |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6720145 Classification of preferential dermatitus; obtain skin sample, recover nucleotide sequences, monitor expression pattern of cytokine, classify dermatitis |
| 04/13/2004 | US6720014 Culturing escherichia coli; genetic engineering and expression |
| 04/13/2004 | US6719972 Induce antigen specific apoptosis in activated t cells; ligands with monoclonal anti-ctla4 antibody that binds to an epitope of ctla4 |
| 04/13/2004 | US6719970 Injecting live chondrocytes and bicompatible, biodegradable polymer microparticles comprising bioactive agent |
| 04/13/2004 | US6719969 High speed hepatocyte proliferation and liver regeneration after injury caused by acetominophen overdose or surgery; side effect reduction of gene therapy |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | US6719901 System for the production of an autologous thrombin |
| 04/13/2004 | US6719805 Devices and methods for treating tissue |
| 04/13/2004 | US6718986 Mixed chimerism and tolerance |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2084347C Method of regeneration of medicago sativa and expressing foreign dna in same |
| 04/08/2004 | WO2004029630A1 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 04/08/2004 | WO2004029629A1 N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses |
| 04/08/2004 | WO2004029576A2 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 04/08/2004 | WO2004029278A2 Aav itr-mediated modulation |
| 04/08/2004 | WO2004029249A1 Immunoglobulin compositions and methods |